Feb. 13, 2022

Molecules of the Month - January 2022

MRTX1719

PRMT5 inhibitor preclinical (MTAP-deleted cancers) from fragment-based design + SBDD J. Med. Chem. Mirati Therapeutics

twitterlinkedinprintemail